Copy of SM_Corporate-PPT

[Virtual Presenter] Greetings and welcome to the initial slide of our corporate presentation. I am a teacher at our highly regarded school and I am pleased to introduce you to our presentation. We will be discussing the progress in pharmaceutical excellence through innovation, quality, and commitment. This presentation is proudly brought to you by www.saimirra.com. Let us now embark on our journey to gain a deeper understanding of corporate excellence in the pharmaceutical sector..

[Audio] Today, the second slide of our corporate presentation discusses Sai Mirra Innopharm - a leading pharmaceutical company with a global presence. Our company operates as a fully integrated group in India, specializing in research and development, manufacturing, and marketing of APIs, formulations, CRO, and bioequivalence services. This allows us to provide high-quality products in over 55 countries, meeting the increasing demand for healthcare solutions. Please continue with the presentation to learn more about our company and its contributions to the pharmaceutical industry..

[Audio] We will be discussing the corporate history of Sai Mirra Innopharm and its evolution over the years. The foundation of Sai Mirra Innopharm was established by American Remedies between 1980 and 1995, marking the early achievements of the company. On the next slide, we will explore the transition and growth of the company from 1996 to 2011. In 1995, Sai Mirra Innopharm achieved TGA approval, solidifying its compliance with global quality standards and establishing itself as a leader in the pharmaceutical industry. In 2000, Dr. Reddy's acquired the plant and rebranded it, leading to an increase in production capacity and expertise. During this period, 25% of Dr. Reddy's products were produced at the Sai Mirra Innopharm facility, contributing to its growth and success. Throughout the years, the plant has undergone various changes and upgrades to stay at the forefront of the industry, playing a crucial role in the company's commitment to innovation and quality. That concludes our discussion on slide number three..

[Audio] Today, we will be discussing slide number 4 in our corporate presentation, which focuses on our company's quality policy. Our quality policy is centered around the goal of delivering quality and affordable medicine to all individuals. We believe that access to quality medicine is a fundamental need and we are dedicated to meeting this need for all. To achieve this goal, we approach medicine development and manufacturing with the same care and attention as a mother preparing food for her child. We pay close attention to every detail to ensure that our products are of the highest quality. But our commitment to quality doesn't end there. We also strive to infuse compassion, love, and goodwill into our products. In doing so, we not only improve the quality of life for our patients, but also show that we truly care about their well-being. Our company's values of innovation, quality, and commitment allow us to work towards our vision of providing the best medicine to every individual and enhancing their quality of life. We continually seek to innovate and add value to our products in order to achieve our mission. With a strong vision and mission, we are confident in our ability to maintain our position as a leader in pharmaceutical excellence. Thank you for listening, and we will continue our discussion on our company in the upcoming slides..

[Audio] Slide number five out of 21 is entitled "We Value..." and showcases our core company values. Our financial stability is essential for success and growth in the pharmaceutical industry. In addition to this, we must conduct our business with integrity and always keep in mind our purpose: improving and preserving human life. Our company values productive creativity and continuous innovation, while also prioritizing efficiency and reducing waste. Our values of mutual respect, personal excellence, trust, and togetherness drive our success, as we recognize the importance of our human capital. It is our goal to consistently deliver high-quality products and services to our customers. At our company, we embrace creativity and innovation and understand the importance of taking risks and pushing boundaries. Finally, we place a strong emphasis on cost effectiveness in order to ensure our financial stability. The following slide will focus on our human capital and how we work together as a team to achieve growth and success..

[Audio] Slide number 6 of our corporate presentation showcases the impressive credentials and achievements of our two managing directors, J. Jayaseelan and Dr. Samy Shanmugam. Jayaseelan, with over 30 years of experience in the pharmaceutical industry, is the founder and director of Nuray Chemicals Pvt. Ltd., a company compliant with USFDA regulations for API production. He is also the managing director of Hibrow Healthcare Pvt. Ltd. and Sai Mirra Innopharm Pvt. Ltd., both USFDA-compliant for formulation, and Delvin Formulations Pvt. Ltd., a well-known branded marketing company. Dr. Samy Shanmugam, a US resident with a M.Pharm degree and three decades of industry experience, has worked in top companies like Ivax, Kali Labs, Par Pharmaceuticals, Novel Labs, and Novitium Pharma in the USA. He has an impressive track record of developing and commercializing over 200 specialty dosage forms and is a registered pharmacist in the state of New York. Both managing directors are highly respected in the industry and are actively involved in various organizations. Jayaseelan is part of the Indian Drug Manufacturers' Association, Indian Pharmaceutical Association, and Indo American Chamber of Commerce, while Dr. Shanmugam is a key member of the Tamil Nadu Pharmacy Council of India. We are honored to have such accomplished leaders at the helm of our company. Thank you for your attention on slide number 6 and stay tuned for more information in our corporate presentation..

[Audio] Slide number 7 of our Corporate Presentation focuses on the key members of our management team. This team is essential in driving our company's pharmaceutical excellence through innovation, quality, and commitment. Our Executive Directors, J Yuvaraj and J J Sugirtha, bring valuable knowledge and experience to guide our company towards success. Our Chief Experience Officer, J J Bharath, has been instrumental in shaping our company's success and growth in the pharmaceutical industry. Together, our management team works tirelessly to keep our company at the forefront of pharmaceutical excellence. Their dedication, vision, and commitment are the driving force behind our success. Thank you for joining us on this slide and for watching our presentation. We hope you now have a better understanding of the crucial role our key management team plays in our company's success..

www.saimirra.com. Organization Chart.

[Audio] Let's now look at the ninth slide of our corporate presentation, where we will discuss the facility brief. Our facility has a total area of 23,024 square feet, which consists of the production block, administration block, raw materials and packaging materials stores, service block, finished goods warehouse, and quality control area. However, we have plans to expand our facility to 58,928 square feet, with additional areas for the production and administration blocks, as well as a proposed area with stores, service block, and warehouse for finished goods. This expansion will help us meet the increasing demand for our products and fulfill our mission of advancing pharmaceutical excellence through innovation, quality, and commitment. Stay tuned for more updates on our company on slide ten..

[Audio] Today, we will be discussing slide number 10 out of 21, which focuses on the capacity of a pharmaceutical facility. The facility has the capability to produce 150 million tablets, 20 million hard gelatin capsules, and 10 million soft gelatin capsules. Additionally, it can also produce 5,00000 litres of sachets containing granules and powders, as well as 2.5 million units of various other products. Having a high capacity facility is essential for meeting client demands and ensuring timely product delivery. With advanced equipment and modern technology, our facility is able to produce a large quantity of high quality pharmaceuticals, demonstrating our commitment to excellence, innovation, and maintaining the highest standards of quality. Our goal is to provide clients with the best possible products and services. By continuously expanding and enhancing our capacity, we can keep up with the ever-changing pharmaceutical industry and maintain our position as leaders in the field. Let's now move on to the next slide to continue learning about various aspects of corporate presentations..

[Audio] Today, we will be discussing slide number 11 out of 21 in our corporate presentation. This slide focuses on the accessibility of our facility and the registered formulations of our products. Our facility is easily accessible for both our employees and clients, allowing for seamless operations and collaborations. Our team works tirelessly to develop and register high-quality and safe formulations. This allows us to offer a diverse and effective range of products to our customers. Our product unique dossiers are a representation of the hard work and dedication put into each product. Our products have exclusivity in at least 15 countries, demonstrating our commitment to global expansion and providing top-quality products. We are proud to have over 1000 accreditations and approvals for our products, highlighting our dedication to maintaining high standards in an ever-changing industry..

[Audio] We are on slide number 12 out of 21, discussing the unique capabilities of our R&D facility. The facility has specialized departments such as Analytical Development and Formulation Development teams that provide comprehensive support for all R&D projects. It has received government approval and accreditation from the DSIR, ensuring our work meets high standards. Our in-house development capabilities, with a team of experts in product and method development, allow for efficient technology transfer to the production floor and Quality Control Lab. We are committed to advancing pharmaceutical excellence through innovation..

[Audio] Let's take a closer look at the production facility as we move onto slide number thirteen. This facility is equipped with advanced process machinery, such as the Glatt Coater, Neocota, Cadmac C200, and Cadpress 45-station double rotary tablet press, for efficient and high-quality production. Our manufacturing approach is also noteworthy, with four dedicated modules for Oral Solid Dosage (OSD) forms and two modules for Oral Liquids, as well as exclusive areas for capsule and sachet production. This modular approach helps streamline processes and ensures top-notch production. Additionally, our facility has a specialized HVAC system with precise pressure balancing and separate units for each module to maintain optimal production conditions. To maintain high hygiene standards, we have strict gowning protocols in place, with individual procedures for each module. Our production areas also have controlled entry and door interlock systems for added security. Thank you for joining us for this presentation on advancing pharmaceutical excellence at our production facility. Please continue to the next slide for more information..

[Audio] The Quality Control (QC) Lab is a crucial part of our pharmaceutical production process, ensuring the highest standards. Let's take a closer look at the advanced analytical instruments found in this lab, starting with 8 High Performance Liquid Chromatography (HPLC) systems integrated with Waters-Empower 2 software for precise analysis. This software, also known as FR2, maintains accuracy and consistency in our results. Other important instruments include the Fourier Transform Infrared (FTIR) spectrophotometer and UV spectrophotometer from Shimadzu, used to identify and analyze compounds, and the Electrolab Dissolution Apparatus, which tests the rate of product dissolution. Additionally, the Gas Chromatography (GC) machine from Perkin Elmer is used to separate and analyze compounds in raw materials and finished products. Our QC lab also has a fully-functional Microbiology Lab, where we conduct comprehensive testing for water quality, environmental monitoring, and microbial limit testing (MLT). We also test products and raw materials for safety and effectiveness. Together, these advanced instruments and comprehensive testing ensure the highest quality in our products. Saimirra Pharmaceuticals is committed to advancing pharmaceutical excellence through innovation, quality, and commitment. On the next slide, we will discuss our corporate social responsibility initiative..

[Audio] As we continue our Corporate Presentation, we have now reached slide number 15 out of 21. This slide focuses on the Quality Assurance processes in place to ensure compliance and product excellence. One of the key aspects of our QA processes is the management of quality-related documents. These activities fall under our Document Management and are crucial in maintaining a high level of quality throughout our organization. In addition, we have measures to handle any deviations or issues that may arise, such as Change Control, Deviation Management, Market Complaints, APQR, Out of Specification, Out of Trend, and Incidents. All of these activities are carefully controlled and documented to ensure accountability and transparency. Our Quality Management System (QMS) is another important element of our QA processes, providing oversight and guidance in maintaining and improving our quality standards. We also have a strong focus on validation of manufacturing processes and cleaning protocols to ensure the safety and effectiveness of our products. This includes both process and cleaning validations, which play a crucial role in maintaining high-quality standards. To ensure our personnel consistently meet the required quality standards, we have implemented continuous training programs to keep our team up-to-date with industry techniques and standards. Regular internal audits are also conducted to uphold our QA standards, identifying potential areas for improvement through self-inspections. Additionally, we conduct proactive risk evaluations to mitigate any potential quality issues and take preventive action to maintain the highest level of quality in our products. Finally, we have thorough equipment and process qualifications in place to maintain compliance, regularly reviewing and updating them to ensure the highest level of quality. In conclusion, our Quality Assurance processes consist of a variety of comprehensive measures to ensure compliance, product excellence, and continuous improvement. We will now move on to our next slide..

[Audio] Slide number 16 focuses on the Packaging facility of our company, which plays a crucial role in efficiently delivering our products to customers. The facility's advanced automation and control systems have streamlined the packaging process and increased productivity. The Automated Packaging section is equipped with Auto Cartonators, allowing for precise packaging of tablets and liquids. The Quality Control system, with an integrated camera system, ensures rigorous checks for maintaining high quality standards. Our facility also has versatile Packaging Machinery, catering to diverse product types. In conclusion, our Packaging facility reflects our commitment to pharmaceutical excellence through innovation and quality, efficiently delivering products to our customers..

[Audio] Today's training will focus on our company's accreditations in the pharmaceutical industry. These accreditations demonstrate our commitment to innovation, quality, and overall excellence. Our company, www.saimirra.com, holds various important accreditations such as PICs Malaysia, WHO, NDA Uganda, Zazibona, FDA Ghana, DR Congo, NAFDAC Nigeria, as well as accreditations from Vietnam, the Kingdom of Cambodia, Myanmar, and Ivory Coast. These accreditations are crucial for our company's credibility and reputation in the pharmaceutical industry, as well as for expanding our operations in different regions and adhering to regulations and standards..

[Audio] In this slide, we will be discussing the significant progress we have made and the strong presence we have established in various countries, such as Tanzania, Peru, Hong Kong, Guatemala, FSSAI in India, Singapore, PMPB in Malawi, the CIS countries, Costa Rica, and Sri Lanka. Our efforts in advancing pharmaceutical excellence through innovation, quality, and commitment have enabled us to establish a presence in these regions. Through partnerships with local organizations, we have been able to provide the best products and services and make a positive impact in the healthcare industry. In Tanzania, our introduction of new and innovative medicines has helped improve the healthcare system and the lives of the people. Similarly, in Peru, our commitment to quality has been recognized. In Hong Kong, we have partnered with local companies to introduce advanced technologies in the pharmaceutical field. Our presence in Guatemala has provided access to affordable and quality medicines, and we are continuously expanding in this region. In India, working closely with FSSAI, we ensure that our products meet safety and quality standards. In Singapore, we are a trusted and reliable healthcare partner, offering a wide range of products and services. Our work with PMPB in Malawi has been recognized for its impact in the healthcare industry. In the CIS countries, through strong partnerships, we have introduced new and innovative products, contributing significantly to the healthcare sector. Similarly, in Costa Rica and Sri Lanka, we have made a positive impact through our focus on high-quality products and services. As we continue to expand and make progress in these regions, our mission remains to advance pharmaceutical excellence through innovation, quality, and commitment. We will now proceed to our final slide..

[Audio] We are now delving deeper into the world of international pharmaceutical excellence. Today, we will focus on slide number 19 which discusses the countries we export to. Africa presents great potential for our industry and we are proud to have a presence in a number of countries including Barbados, Benin, Botswana, Burkina Faso, Cameroon, Congo Brazzaville, DR Congo, Ethiopia, Gabon, Guinea, and Ghana. Moving on, we have also expanded our reach to countries in Asia, specifically Cambodia, Hong Kong, Laos, Malaysia, Myanmar, Nepal, the Philippines, Singapore, Sri Lanka, Tajikistan, Uzbekistan, and Vietnam. Our commitment to excellence has also led us to establish a strong presence in Latin American countries such as Bolivia, Ecuador, El Salvador, Costa Rica, Cuba, Chile, the Dominican Republic, Guatemala, Honduras, Haiti, Jamaica, Panama, Peru, and Venezuela. Additionally, we have a significant presence in various African countries including Madagascar, Mali, Malawi, Mauritania, Mauritius, Namibia, Niger, Nigeria, Rwanda, Senegal, Sierra Leone, Tanzania, Togo, Uganda, Zambia, and Zimbabwe. As we continue to push the boundaries of pharmaceutical innovation, let us not forget the impact we are making in different regions of the world. Thank you for joining us and stay tuned for our final slide..

www.saimirra.com. Thank You.